Małgorzata Kujawska, Ph.D., D.Sc., is a Professor at Poznan University of Medical Sciences (Poznan, Poland). She graduated with an MSc. and Ph.D. with a postdoctoral degree (habilitation) in pharmaceutical sciences. Her research work is focused on therapeutic and neuroprotective approaches against neurodegeneration in synucleinopathies models. She is an experienced Principal Investigator of interdisciplinary projects implemented within international cooperation. Her current research project is "New graphene-based approach targeting the prion-like propagation of α-synuclein in Parkinson’s disease.” Prof. Kujawska integrates nanotechnology and neuroscience in her research. She is an enthusiast of nanoneuroscience based innovations in synucleinopathy management. Gut neuromicrobiology that encompasses understanding the interplay between the gut microbiota, its neurometabolic interactome, and Parkinson’s disease is her second research hotspot. She is an author of pioneering studies on neuroprotective activity of ellagic acid-derived gut microbiota metabolite - urolithin A in an in vivo PD model. She studies on microbiome-targeted interventions to slow progressing synucleinopathy from the gut to the brain. Prof. Kujawska is experienced in conducting in vivo studies, including toxicity testing. Prof. Kujawska is a recipient of the 2020 Matsumae International Foundation Research Fellowship Program. She completed workshops on entrepreneurship and design thinking at Stanford University within the government program “Top 500 Innovators”. She participated in the internship in NASA Ames Research Center at Synthetic Biology Innovation Lab. Prof. Kujawska i an author of more than 80 article mainly as a first or last and corresponding author in scored journals, several speeches, including as a invited speaker, during international conferences. She is experienced organizer of scientific international meetings. Total number of citations is 1825, hi-23. Prof. Kujawska serves as President of the Poznan Branch of the Polish Society of Toxicology. She is also a member of other scientific societies, including FENS and RCS. She is in the Top 1% of reviewers for pharmacology & toxicology and cross-field, according to Publons (Web of Science). She is a member of an editorial boards in several scientific journals covered by JCR. She is the winner of several Rector’s awards for scientific achievements. Prof. Kujawska also served as a scientific evaluator for Polish and foreign agencies financing R&D activities. She is also a member of the Sectoral Council for Competences of the Chemical Sector. Prof. Kujawska is an experienced reviewer with above 300 reviews for more than 80 various journals according to ORCID report. She is salso an author of a few editorials for scored journals. Her professional goal is to successfully combine neuroscience with nanotechnology in research on novel approaches for managing Parkinson’s disease. My personal goal refers to building for this purpose a nanonuneuroscience networking platform enabling this community to communicate effectively. Prof. Kujawska represents leadership, management, and problem-solving, which she leverages during project implementations. Moreover, she is an experienced mentor in several mentoring programs for women in STEM. Her hobby is traveling and solving Sudoku puzzles.